Global Prostate Cancer Drug Market Forecast and Market Analysis to 2023

Posted by David Lee at 00:17 on Friday 10 July 2015
ALBANY, NY, July 2015 -- ResearchMoz.us includes new market research report " Prostate Cancer - Global Drug Market to 2023: Global Idnustry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

Prostate cancer is the second most common cancer in men worldwide, after skin cancer. It accounts for 15% of all the cancers diagnosed in men, and thus represents a huge burden on healthcare systems. While patients diagnosed with early-stage, localized prostate cancer can be cured, patients who are diagnosed with or progress to castration-resistant prostate cancer (CRPC) have no curative options. This report focuses on the current treatment landscape, unmet needs, pipeline assessment and market outlook for prostate cancer. Since 2010, five new drugs have been approved for the treatment of CRPC: Dendreons Provenge, Sanofis Jevtana, Johnson & Johnsons Zytiga, Medivation/Astellas Xtandi, and Bayers Xofigo. During the forecast period from 2013-2023, GlobalData expects that nine new late-stage pipeline agents will launch, eight of which will be for the treatment of CRPC. 

As a result of this unprecedented level of clinical development, GlobalData predicts there will be massive changes in the CRPC treatment paradigm. In addition, due to the influx of new therapies, the size of the prostate cancer market across the nine major pharmaceutical markets (9MM) (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and Canada) will increase three-fold.


Highlights:-

  • - How will prostate cancer disease management change as new agents enter the market?
  • - Which prostate cancer patients have the greatest unmet needs and how well will these needs be addressed by the new agents?
  • - What are the most dominant players in the prostate cancer space and what corporate strategies are pursued by these companies?
  • - What are the most promising late-stage pipeline agents for prostate cancer? How do they compare to currently marketed products?
  • - What opportunities will remain for future players following the launch of these pipeline agents?

Click Here To Download The sample Copy Of This Report: http://www.researchmoz.us/enquiry.php?type=sample&repid=295880

Scope:-

  • - Overview of prostate cancer, including epidemiology, etiology, pathophysiology, clinical staging, symptoms, prognosis, quality of life, and disease management.
  • - Annualized prostate cancer therapeutics market revenue from 2013-2023. Annual cost of therapy, and major marketed and pipeline drug sales in this forecast period are included.
  • - Key topics covered include strategic competitor assessment, market characterization, unmet needs, and implications for the prostate cancer therapeutics market.
  • - Pipeline analysis: The prostate cancer pipeline is robust with many late-stage candidates set to launch in the forecast period. Comprehensive analysis of the nine most promising candidates in Phase III development are highlighted and profiled.
  • - Analysis of the current and future market competition in the global prostate cancer therapeutics market, including insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy:-

  • - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • - Develop business strategies by understanding the trends shaping and driving the 9MM prostate cancer market.
  • - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 9MM prostate cancer therapeutics market in the future.
  • - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
  • - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.



About Us:

ResearchMoz is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.

For More Information Kindly Contact: 
Mr. Nachiket
Tel:+1-518-618-1030 
Toll Free: 866-997-4948
Labels: , , ,

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)